NGEN.V - NervGen Pharma Corp.

TSXV - TSXV Real Time Price. Currency in CAD
Currency in CAD
Earnings EstimateCurrent Qtr. (Mar 2023)Next Qtr. (Jun 2023)Current Year (2023)Next Year (2024)
No. of Analysts0010
Avg. Estimate00-1.050
Low Estimate00-1.050
High Estimate00-1.050
Year Ago EPS-0.11-0.13-0.39-1.05
Revenue EstimateCurrent Qtr. (Mar 2023)Next Qtr. (Jun 2023)Current Year (2023)Next Year (2024)
No. of Analysts0011
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2022-03-302022-06-292022-09-292022-12-30
EPS Est.-0.08-0.11-0.14-0.12
EPS Actual-0.11-0.13-0.08-0.1
Difference-0.03-0.020.060.02
Surprise %-37.50%-18.20%42.90%16.70%
EPS TrendCurrent Qtr. (Mar 2023)Next Qtr. (Jun 2023)Current Year (2023)Next Year (2024)
Current Estimate00-1.050
7 Days Ago00-1.050
30 Days Ago00-1.050
60 Days Ago00-1.050
90 Days Ago00-1.050
EPS RevisionsCurrent Qtr. (Mar 2023)Next Qtr. (Jun 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNGEN.VIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current Year-169.20%N/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A